SENS Senseonics is waiting for FDA`s approval for the 180-day version of its Eversense CGM system.
Eversense can generate as much as $200 million in sales by 2025.
HC Wainwright sees a 6usd price target for it.
And let`s not forget it`s a meme stock.
This figure is not confirmed yet.
Must break the 4$ resistance with volume to confirm.
If confirmed:
Price target = 7.50$
Stay humble, have fun, make money!
$SENS looks like it is breaking out of this symmetrical triangle. Volume is currently dying down so waiting on a pullback to enter. FDA approval is in the air and now wouldn't be a bad time to scale in! PT is previous high of $4.58 level.
Pulled SENS back up again after a few weeks and see that it's still holding the same fib and trendline levels as it was when we first drew out the fib retracement. It's also now holding the 50DMA consistently as it steadily rises. For some context, this company develops and commercializes continuous glucose monitoring systems for diabetes patients. Senseonics...
Noted in the trend band, $SENS has floated within its average for the last 3 months, with a small upward move from its initial 180 day CGM submission to the FDA. Although $SENS has report net loss, it is expected from a company within its product growth cycle. Additionally, new employees were hired to speed the R & D of its programming and engineering. New...
Here we have a bullish bat pattern, on the daily. I would enter at the top of the entry envelope. Widening the PRZ, I added the extra 1.618 extension below the retracement entry envelope because there appears to be an extension pattern that suggests some drawdown passed the 0.886 retracement. I'd keep stop loss at 5% below 1.74. Good luck, trade safely, and...
The thing about SENS is that it's been a company crushing it in 2021. When it was first discussed this year it was still trading below $1. Despite recent volatility, it's up significantly year-to-date. I think volume remains steady but definitely on the lower end of the range. But good data from the last presentation on its PROMISE study seems to have sparked...
Either a Wave 4 WXY pattern or a more general turnaround. Both scenarios are bearish. Note divergences and dropping momentum also.
We are not in the business of getting every prediction right, no one ever does and that is not the aim of the game. The Fibonacci targets going down are highlighted in purple with invalidation in red. Fibonacci goals, it is prudent...
clean 1-2-3-4-5 into the (1)
now we get an a-b-c down into my golden zone for the (2),
where i will become a buyer.
wave 3 target - 12
wave 5 target - 30+
Senseonics Holdings, Inc. engages in the design, development, and commercialization of implantable continuous glucose monitoring system for people with diabetes. Its primary product is the brand Eversense, a gluscose monitoring device which includes sensor, smart transmitter, and mobile application. The company was founded on June 26, 2014 and is headquartered in Germantown, MD.
Arca
